Turns out that COVID vaccination would ideally have been a 3-dose course (day 0, Day 21-28, & one more shot at 6 months), akin to what we do when vaccinating kids & even adults against many pathogens. But ideals are going to be compromised… here’s why…cdc.gov/vaccines/paren…
Data from all major vaccine trials now show that immunity wanes gradually after first two shots… AND the virus mutates to build its resistance (ie delta variant). 2/
Vaccines still protect at 6m, but while their efficacy was 95% against original strain shortly after the peak of immunity after the 2nd dose, it drops down to being 40-80% protective against delta infection by 6m (still something!). 3/
What’s key though is that after 6m, vaccine still great at blunting disease severity, making you 7-12x less likely to be hospitalized IF infected than if you weren’t vaccinated & got infected (ie 85-92% protection against hospitalization-grade covid). medrxiv.org/content/10.110…
But waning immunity against any infection means the virus can still spread (mildly or even unnoticed) through many vaccinated people as we get out 6m past vaccination, until it finds vulnerable people for whom even a 15% residual risk of hospitalization is high. 5/
And of course there are the willfully unvaccinated. As much as everyone else may wish that they would get vaccinated (and I do support mandates), everyone deserves what herd immunity the rest of us can offer. So that’s where the 3rd dose comes in. 6/
Data from Moderna, Pfizer/BioNtech, & Novavax show 3rd dose can rocket neutralizing antibody levels up even higher (~4x) than they were after 2nd dose. That offers strong protection against all variants could plausibly last a year. cnn.com/2021/07/28/hea…
Ideally, everyone would get 3rd dose of a vaccine around 6m or as soon thereafter as possible. But we don’t have enough doses for that while we try to get even the first 2 doses out to the rest of the world so they can benefit from the protection we’ve enjoyed. Does CDC agree? 8/
Not quite. Like CDC initially played down masks to prevent shortage for healthcare workers (then reverse itself), CDC is avoiding saying 3rd dose is needed. But as w/ masks, once supply issues solved, CDC will likely acknowledge logic of 3rd dose for primary vaccination schedule.
By then, odds are few of us who got our initial shots early 2021 will be within 6 months of our first dose. So ideals are necessarily being compromised. We’ll simply have to make do with getting that 3rd shot whenever it becomes available. We’ll do better in future pandemics. 10/
Some may take a nationalistic approach and say “America paid for the doses so Americans should get all they want”. Ok, but that’s just one perspective. Maybe that’s not the kind of country we should be. & helping end global pandemic helps America, too. 11/
Still, I could see American administration trying to do both, have America be a good globally citizen but also skew a bit towards protecting Americans better. We are already seeing recommendations to give a 3rd dose to immunocompromised people. 12/
As supply expands, recommendations could be expanded to giving 3rd dose to everyone over 70, 60, 50, etc, as we saw w/ initial vaccine rollout. Healthcare workers & teachers should again be prioritized to offer stronger herd immunity to those they protect. 13/
Many of us still do what we can to shield our unvaccinated kids. Their risks are indeed low from COVID, but reports of complications from even mild infections are unsettling. So until we know more, we shield ours. Fortunately, studies for kids ages 6m & up are underway. 14/
While data from pediatric studies are officially projected to come next year, my guess is we’ll see them much sooner. I don’t doubt they’ll be effective in kids; that’s not really in question. FDA understandably wants to see safety to make sure we know benefit-risk trade-off. 15/
Once kids are vaccinated, parents might worry less about their own waning immunity not offering herd protection to their kids. So that 3rd shot wouldn’t feel as urgent. But right now, I hate thinking that my waning immunity could let me pass the virus to my unvaccinated kids.
It’s that herd immunity issue that makes masks rational even for the vaccinated. No sense bringing the virus home to your unvaccinated kids. Once they are vaccinated, we don’t have to hope for herd immunity as much. 17/
But even mild COVID isn’t fun, & masks protect against other infections. So even if just thinking about yourself, esp the further out you get from vaccination, consider merits of masks in at least some public setting, especially crowded indoor ones. 18/
Of course, if you have any member of your family who resists vaccination and who you really love (I’ve got one), then keeping yourself from getting infected is all you can do to protect them. So you’ll want a 3rd dose and/or to wear a mask (also helps muffle your grumbling). 18/
Technically, those who already had an infection can consider that to be like first shot, so they likely would be fine w/ one shot and then a 2nd one 6 months later. JNJ vaccine counts as 2 shots; getting extra shot of other vaccine good idea when you can. 19/
You might think if we need shot at 6 months, maybe need shot every 6m. It’s possible, esp w/ new@variants (yikes Vega! kidding, not a Greek letter), but again, data show that antibody levels after 3rd shot are even higher than after 2nd. So protection likely better, longer. 19/
And once kids of vaccine-accepting parents can be vaccinated, these parents won’t fear a rising risk of mild infection as long as can count on everyone being protected against serious infection. So annual shots will likely be good enough for long run (mix w/ flu vaccine). 20/
Tolerability… mRNA vaccines are as uncomfortable when you get 6m booster as after 2nd shot. They really rev up immune system. It may put some off. But older people, who need 6m booster most, actually tolerate mRNA much better than younger people, so if it’s available, take it.
Fortunately protein-based vaccines are coming (I know, like waiting for Godot…), good for two reasons: 1) they are better tolerated than mRNA and 2) they will dramatically increase global supply, easing guilt over getting 3rd dose when others haven’t gotten first two. 23/
Bottom line: when 3rd dose is available to you, whether at 6 months or anytime after, it makes sense to take it. It will help you & protect others around you. If I had to guess, boosters will be available to all who want them in US by YE21. 24/
Since I wrote thread, US announced that it will roll out 8 month booster shots. That’s great. Realistically can’t deploy quickly enough to get everyone a dose by 6m. So 8m is realistic goal. Means those who got 1st dose Feb-April will get booster by Oct-Dec. Aug/Sept less fun.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Peter Kolchinsky

Peter Kolchinsky Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @PeterKolchinsky

10 Sep
Dear Lawmakers @POTUS @RonWyden @SpeakerPelosi Hundreds of us biotech investors, innovators, patient advocates, & NIH academics representing >40k US jobs, >600 drugs in trials, & >$200B invested propose solutions to affordability that preserve R&D. 1/
nopatientleftbehind.docsend.com/view/a6bxibzxy…
This is grassroots, not PhRMA. We offer solutions! We support real negotiation: play products off one another to get better prices. Help patients by lowering what insurance can demand OOP for medicines they need. And save by ensuring all drugs go generic w/o undue delay. 2/
But you must not redefine the word “negotiation” to mean that government can just dictate the price of a new drug & force a company to accept it under threat of a ruinous tax. That’s not negotiation, even if you like calling it that. That’s a repudiation of basic economics. 3/
Read 14 tweets
26 Aug
Wow. Reporting by @jeffreybillman on medical debt collectors, why they hate their work & who they blame, may make you cry or vomit. Thank you @NPLB_org for covering. Many gutting quotes. 115,000 do this work, few love it. More attention: @NPR @nytimes nopatientleftbehind.org/publications/a…
What if it worked like this for all appropriately prescribed treatments?
And you don’t have to accept the injustices of medical debt collection. Defend yourselves by knowing your options. Read more here. Again, thank you for great coverage by @NPLB_org nopatientleftbehind.org/publications/w…
Read 4 tweets
22 Aug
Focusing on EpiPen, academics suggest patents on device improvements are problem. They acknowledge patents may be essential to incentivizing valuable improvements yet lament poor patient access. Yet never mention “INSURANCE” (except one footnote). How did peer review miss it?
Must we reinvent innovation incentives to fix what are clearly failings of insurance design in America? How about proper insurance w/ low out of pocket costs. To then save $ for society AS A WHOLE, enforce genericization w/o undue delay. This is for you: nopatientleftbehind.org/about/our-vide…
But whenever patients can’t afford a drug, first thought should be whether insurance is doing what it’s supposed to. If not, propose fixing it. If you think society as a whole is overpaying for something, present evidence for why & then let’s talk about solving market failures.
Read 4 tweets
11 Aug
Consider controversy whether pharma sales & marketing is necessary. For COVID, gov’t distributes vax w/o companies doing marketing. Data are out there. People still unclear, say gov’t isn’t teaching right. New drugs w/o understanding of their utility are a wasted effort. 1/13
In some cases, it seems marketing can be harder than R&D. The drug industry does spend more on R&D than on sales & marketing, but that’s arbitrary & shouldn’t be seen as inherently right. They aren’t relative expenses. They are each essential. 2/
We should spend what we must on R&D, and we should spend what we must to ensure all the right people are informed and suitably convinced of the utility of each new medicine. Only then will innovation have made a difference. 3/
Read 14 tweets
16 Jul
Math is precise, but doesn’t make it accurate. Formulas health economists use calculate a drug’s value rely on uncertain human inputs. @SpeakerPelosi, don’t import this math from Europe. Errors can brand a drug as “not worth it” even when it is. Help patients by fixing insurance.
I’m not saying that one can’t attempt to appreciate how much value a drug generates for society. I’m saying that one should be very careful about math that attempts to override the market to set prices. The math can and should be improved. Here’s how. global-uploads.webflow.com/606ac6e3ee6c27…
And if you are curious about why price controls based on bad math would kill innovation, here’s a step by step explainer of the murdering process. nopatientleftbehind.docsend.com/view/b65fjkcdi…
Read 5 tweets
13 Jul
Hmmm… Drug companies develop meds to keep people out of hospitals, go out of their way to offer patients copay assistance, & get vilified & sued for it. By contrast, hospitals hound patients mercilessly for last $. How will Congress prioritize? @NPLB_org axios.com/hospital-billi…
If you want some tips on how to deal with predatory hospital billing, check out articles on nopatientpeftbehind.org. There is advice on who to call, what to say, what not to sign, etc. And sadly lots of people who have been left behind. We’re working on solutions. @NPLB_org
And if that axios link didn’t work for you. Lots of related articles on hospital predatory billing. axios.com/hospitals-pati…
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(